A detailed history of Denver Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Denver Wealth Management, Inc. holds 13,399 shares of PFE stock, worth $353,197. This represents 0.19% of its overall portfolio holdings.

Number of Shares
13,399
Previous 13,408 0.07%
Holding current value
$353,197
Previous $375,000 3.2%
% of portfolio
0.19%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $249 - $282
-9 Reduced 0.07%
13,399 $387,000
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $12,200 - $14,296
483 Added 3.74%
13,408 $375,000
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $440 - $505
17 Added 0.13%
12,925 $358,000
Q4 2023

Jan 23, 2024

BUY
$26.13 - $33.94 $12,202 - $15,849
467 Added 3.75%
12,908 $371,000
Q3 2023

Oct 24, 2023

BUY
$32.09 - $37.51 $7,894 - $9,227
246 Added 2.02%
12,441 $412,000
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $32,544 - $37,652
-901 Reduced 6.88%
12,195 $447,000
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $4,411 - $5,743
112 Added 0.86%
13,096 $534,000
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $32,231 - $42,074
-772 Reduced 5.61%
12,984 $0
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $4,857 - $5,929
111 Added 0.81%
13,756 $602,000
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $16,099 - $19,088
346 Added 2.6%
13,645 $715,000
Q4 2021

Feb 17, 2022

SELL
$41.32 - $61.25 $206 - $306
-5 Reduced 0.04%
13,299 $785,000
Q1 2021

Apr 26, 2022

BUY
$33.49 - $37.77 $445,550 - $502,492
13,304 New
13,304 $689,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Denver Wealth Management, Inc. Portfolio

Follow Denver Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denver Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Denver Wealth Management, Inc. with notifications on news.